Clinical Research Directory
Browse clinical research sites, groups, and studies.
Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation
Sponsor: University Hospital, Limoges
Summary
Natural Killer (NK) and B cell immune responses occur during the early stages of infection and are essential to eradicate it. Yet, chronic hepatitis B (CHB) infection occurs because the antiviral immune response is insufficient. In both NK and B cell studies we will explore the genetic alterations that occur during the varied chronic stages of the disease. We believe that our findings will allow us to understand the molecular signature of NK and B cells in the context of HBV infection.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2025-08-12
Completion Date
2028-10-01
Last Updated
2025-09-16
Healthy Volunteers
Yes
Conditions
Interventions
blood sample HBV patient
During a boold sample at only one follow up visit: * 3 tubes EDTA 10 ml per patient * 1 tube "Paxgene" 1ml * 2 dry tube per patient
blood sample healthy volunteers
* 3 tubes EDTA ideally age and sex matched to CHB patient. * 1 tube "Paxgene" 1ml * 2 dry tube
Locations (3)
Centre d'Investigation Clinique
Limoges, France
Limoges University Hospital
Limoges, France
Hospice civils de Lyon
Lyon, France